Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antroquinonol in Hypercholesterolemia and Hyperlipidemia
NCT02719028Phase 2Completed
- Sponsor
- Golden Biotechnology Corporation
- Start
- May 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antroquinonol in hypercholesterolemia, hyperlipidemia, sponsored by Golden Biotechnology Corporation. Started May 2016; status: completed.
02
Drugs
antroquinonol
03
Conditions
hypercholesterolemiahyperlipidemia
Beyond the preview
Go deeper on NCT02719028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02719028.